Crossmark

Molecular and epigenetic features of melanomas and tumor immune microenvironment linked to durable remission to ipilimumab-based immunotherapy in metastatic patients

Crossref DOI link: https://doi.org/10.1186/s12967-016-0990-x

Published Online: 2016-08-02

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Seremet, Teofila https://orcid.org/0000-0002-3789-6256
Koch, Alexander

Jansen, Yanina

Schreuer, Max

Wilgenhof, Sofie

Del Marmol, Véronique

Liènard, Danielle

Thielemans, Kris

Schats, Kelly

Kockx, Mark

Van Criekinge, Wim

Coulie, Pierre G.

De Meyer, Tim

van Baren, Nicolas

Neyns, Bart
Funding

Funding for this research was provided by:

Belgian Goverment, Federal Public Service Health, Food Chain Safety and Environment (CancerPlan Action 29-024)

Agentschap voor Innovatie door Wetenschap en Technologie (grant 130894)

Document is current

Any future updates will be listed below